Noopept Powder
€ 74,75 – € 645,00Price range: € 74,75 through € 645,00
Noopept Powder is described as a synthetic peptide-derived research material associated with N-phenylacetyl-L-prolylglycine ethyl ester, also known as omberacetam.
The named compound is a small molecule containing peptide-related structural features and is discussed in experimental pharmacology and neuroscience literature.
The supplied source identifies a lyophilized powder presentation intended for controlled analytical and non-clinical laboratory research.
Its stated scientific context includes chemical characterization, analytical method development, and investigation of neurotransmission-related molecular pathways in experimental systems.
The source reports CAS number 157115-85-0, molecular formula C₁₇H₂₂N₂O₄, and an approximate molecular weight of 318.4 g/mol. The formula and molecular weight are arithmetically consistent.
However, the actual batch identity, claimed purity, physical presentation, and storage stability have not been independently verified.
The source refers to analytical verification, batch tracking, and Certificate of Analysis-style documentation where applicable, but no actual supporting reports were supplied.
The material is not established as a certified reference material or validated quantitative calibration standard.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Noopept Powder – Omberacetam Research Material
Product Overview
Noopept Powder refers to a research material described as containing N-phenylacetyl-L-prolylglycine ethyl ester, commonly known as Noopept or omberacetam.
The named compound is a synthetic small molecule with peptide-derived structural features.
It is discussed in experimental pharmacological literature in connection with investigations of neurotransmission-related molecular pathways and neurotrophic-factor-associated signaling.
The supplied source identifies the product as a lyophilized powder intended for controlled analytical and neuroscience-oriented laboratory research.
However, no actual product-specific inspection report, analytical identity certificate, or manufacturing record accompanied the supplied information. Noopept Powder
The claimed lyophilized presentation therefore remains a source-provided specification.
The source emphasizes documented handling, chemical characterization, purity assessment, and batch traceability.
These statements describe the intended research positioning but do not independently establish product quality or regulatory compliance.
The supplied information also identifies Noopept as a compound of interest in non-clinical investigations involving glutamatergic and cholinergic neurotransmission.
Such scientific contexts should be distinguished from product-specific experimental findings.
No receptor-binding dataset, biological activity report, or validated assay result for the actual batch was supplied. Noopept Powder
Noopept Powder is not established here as a certified reference material, validated quantitative calibrator, or approved pharmaceutical preparation.
Chemical Identity & Classification
The supplied source identifies Noopept as N-phenylacetyl-L-prolylglycine ethyl ester, also known as omberacetam.
Its chemical structure contains peptide-related functional groups and an ethyl ester.
The supplied chemical information includes:
- Common designation: Noopept
- Alternative designation: Omberacetam
- Chemical name: N-Phenylacetyl-L-prolylglycine ethyl ester
- Reported CAS Registry Number: 157115-85-0
- Reported molecular formula: C₁₇H₂₂N₂O₄
- Approximate molecular weight: 318.4 g/mol
- Chemical classification: Synthetic peptide-derived small molecule
- Reported presentation: Lyophilized powder
- Intended designation: Research Use Only
The reported molecular formula corresponds to an approximate molecular weight of 318.37 g/mol, consistent with the source’s rounded value.
This arithmetic consistency does not independently verify the identity of the actual product batch.
The chemical name identifies an L-prolyl structural component, but the supplied information does not include a batch-specific stereochemical verification report.
The source also does not establish whether the actual product contains a particular salt, solvate, or other formulation component.
These details may be relevant when interpreting analytical measurements and quantitative material specifications. Noopept Powder
Researchers may consult PubChem for public chemical-reference information, while ensuring that the selected database entry corresponds to the actual chemical form and stereochemical designation being examined.
Chemical & Physical Characteristics
The supplied source describes the product as a lyophilized powder.
Lyophilization is a processing technique involving removal of frozen solvent under reduced pressure.
However, the source does not provide a manufacturing record establishing that this particular product underwent lyophilization.
No actual product-specific inspection report, particle-size measurement, melting-point determination, or quantitative solubility profile was provided.
The stated physical presentation therefore remains a source-provided description.
Noopept contains a phenylacetyl group, a proline-derived structural unit, and a glycine-derived ethyl ester segment.
These structural features distinguish the named compound from larger polypeptides and chemically unrelated small molecules.
However, structural classification alone does not establish experimentally verified solubility, stability, or other physicochemical characteristics of the actual product.
The source does not provide measured melting-point data, degradation profiles, residual-solvent results, or complete physical characterization. Noopept Powder
The source recommends dry, low-temperature storage in tightly sealed containers protected from moisture and prolonged light exposure.
It also refers to cold storage of prepared solutions and limited solution-use periods.
No validated product-specific stability study, solution-stability dataset, or established shelf-life specification accompanied those recommendations.
Noopept Powder Purity & Analytical Verification
The supplied source describes Noopept Powder as high purity and refers to analytical verification, commonly above 98% by HPLC or LC-MS where documented.
However, no actual batch-specific Certificate of Analysis or laboratory report accompanied the information.
The stated purity threshold therefore remains a supplier-provided claim rather than an independently verified result.
No chromatogram, mass spectrum, NMR spectrum, impurity profile, or independent laboratory certificate was supplied.
Accordingly, no specific purity result can be confirmed for the actual product batch.
The source identifies analytical method development and reference-oriented research as intended laboratory contexts.
Chemical characterization may involve examination of molecular identity, structural features, impurity profiles, stereochemical composition, and analytical specificity.
However, naming an analytical technique does not establish that the actual product has undergone that test.
The source also describes the material in reference-oriented terms. Noopept Powder
That description does not establish certified reference-material status or validated quantitative calibration performance.
No assigned measurement values, uncertainty statements, metrological traceability records, or independently verified analytical specifications were supplied.
Any definitive product-specific analytical claims should be supported by actual batch documentation.
Quality Control & Batch Integrity
The supplied source refers to batch tracking, identity verification, purity data, and Certificate of Analysis-style documentation where applicable.
These statements describe proposed or claimed quality-assurance practices.
No actual certificate, independent testing report, manufacturing audit, laboratory accreditation record, or batch-specific quality-control document accompanied the information.
They therefore remain unverified supplier statements.
For reproducible scientific documentation, relevant records may include verified chemical identifiers, confirmed chemical form, stereochemical information where available, batch number, analytical findings, receipt date, and available storage history.
Where a lyophilized presentation is claimed, manufacturing and residual-solvent documentation may also be relevant to verifying that designation.
The supplied information does not establish independently verified purity, chemical form, or batch consistency.
The existence of a Research Use Only designation does not itself demonstrate manufacturing quality or analytical traceability.
Claims of consistent purity, identity, and manufacturing quality should be supported by actual records rather than inferred from general quality-assurance language.
Safety, Handling & Laboratory Precautions
Noopept is a synthetic small-molecule compound discussed in experimental pharmacological research.
The supplied source does not provide a complete product-specific toxicological assessment.
Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.
Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.
The powder presentation does not establish safety for human or veterinary exposure.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Because the actual chemical form, purity, stereochemical composition, and physical characteristics have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes sealed vials or sachets, protective packaging, controlled handling, and international shipping arrangements.
No actual packaging specification, container-validation report, or shipment-condition record was provided.
The source recommends desiccated, low-temperature storage in tightly sealed containers protected from moisture and prolonged light exposure.
It mentions approximately −20°C as a commonly recommended storage condition.
However, no validated product-specific stability study was supplied to establish that temperature as a verified requirement or to support a particular shelf life.
The source also recommends cold storage and limited holding periods for prepared solutions.
No solution-stability data accompanied those recommendations.
Laboratory inventory records should preserve the product designation, confirmed chemical form where available, any batch identifier, receipt details, and relevant storage observations.
Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional laboratory procedures.
Noopept Powder Intended Research Use & Market Positioning
The supplied scientific context places Noopept within analytical and non-clinical neuroscience research involving peptide-derived small molecules and neurotransmission-related pathways.
The source describes research interest in glutamatergic and cholinergic signaling, neurotrophic-factor-associated processes, and experimental molecular mechanisms.
These contexts identify areas of scientific investigation but do not establish product-specific pharmacological performance.
No independently verified biological activity dataset for the actual powder was supplied.
The supplied Raw Lab Chems catalog includes Noopept Powder, corresponding to the listing discussed here.
For comparative product-format context, Raw Lab Chems also lists Noopept Pellets and Noopept Tablets.
These listings refer to the same named compound in different product presentations.
However, the supplied information does not establish equivalent chemical forms, ingredient purity, excipient composition, or analytical characteristics across the powder, pellet, and tablet preparations.
For compressed preparations, labeled ingredient quantity and finished-unit content uniformity are distinct from ingredient purity.
These catalog references should not be interpreted as evidence of analytical equivalence, certified reference-material status, or validated calibration performance.
Ordering, Availability & Fulfillment
The supplied source describes protective packaging and international shipping arrangements.
No current inventory record, shipment authorization, carrier documentation, or verified delivery information was supplied.
Consequently, no availability, delivery, customs-clearance, or transportation-compliance guarantee is asserted.
The regulatory treatment of Noopept may depend on the jurisdiction, chemical classification, import requirements, and intended laboratory activity.
Institutional acquisition, possession, transportation, importation, and exportation should be assessed under applicable laws.
Research-only labeling does not independently establish a regulatory exemption.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Noopept is a synthetic peptide-derived small molecule discussed in non-clinical pharmacological research.
Its acquisition, possession, transportation, importation, exportation, and laboratory investigation may be subject to applicable chemical, pharmaceutical, customs, and institutional requirements.
The supplied information does not establish universal legal status or regulatory authorization.
Institutions remain responsible for determining the applicable requirements and obtaining any necessary permissions.
No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.
| Quantity (grams) |
5 ,10 ,25 ,50 ,100 |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.